WTL
1.39 / 177.14M
0.01
|
KEL
5.31 / 124.13M
-0.08
|
HASCOL
11.23 / 105.01M
-1.16
|
FFL
11.74 / 77.70M
0.27
|
TBL
16.47 / 43.78M
-0.31
|
BOP
6.75 / 36.57M
0.07
|
SSGC
22.11 / 32.72M
-2.42
|
PIAHCLA
16.79 / 27.97M
-1.84
|
CNERGY
4.49 / 25.87M
-0.14
|
PIBTL
7.39 / 24.11M
-0.27
|
TRG
58.22 / 20.64M
-3.10
|
WAVESAPP
10.95 / 20.36M
-0.51
|
KOSM
7.72 / 19.63M
-0.68
|
HBL
144.70 / 19.34M
9.80
|
SILK
0.91 / 15.88M
-0.01
|
NBP
63.51 / 14.85M
3.22
|
PTC
17.50 / 14.32M
-0.96
|
FABL
52.13 / 13.49M
3.54
|
PRL
25.79 / 12.92M
-0.94
|
PAEL
25.71 / 12.60M
-0.94
|
KAPCO
34.71 / 11.05M
1.08
|
ASL
8.10 / 9.51M
-0.47
|
FCCL
32.77 / 9.45M
0.00
|
LOTCHEM
18.26 / 9.43M
-1.21
|
GCIL
14.23 / 9.21M
0.16
|
QUICE
6.79 / 8.79M
-0.02
|
OGDC
194.69 / 8.79M
-4.97
|
TELE
7.86 / 8.79M
-0.45
|
PACE
5.45 / 8.71M
-0.36
|
BAFL
73.01 / 8.61M
6.19
|
PSO
269.21 / 8.49M
3.13
|
AKBL
31.19 / 8.21M
1.92
|
DGKC
80.96 / 7.97M
-2.81
|
PIAA
22.17 / 7.47M
1.52
|
DFML
40.82 / 7.37M
-0.87
|
TREET
16.27 / 7.20M
-1.20
|
SNGP
83.62 / 6.95M
-2.72
|
POWER
6.92 / 6.61M
-0.35
|
PPL
155.45 / 6.52M
-2.47
|
FFBL
74.43 / 6.19M
-1.04
|
GGL
11.36 / 6.07M
-0.48
|
FFC
322.33 / 5.80M
-3.47
|
TPLP
8.40 / 5.61M
-0.66
|
SEARL
78.65 / 5.60M
-3.79
|
MEBL
257.44 / 5.50M
22.40
|
HUBC
109.58 / 5.50M
-0.97
|
SLGL
15.77 / 5.33M
-0.81
|
HUMNL
13.75 / 5.32M
-0.81
|
ILP
64.38 / 5.25M
-0.97
|
WAVES
7.38 / 5.06M
-0.67
|
Standard Capital
Committed to Intelligent Investing
+9221-111-111-721
 
+92-321-829-6919
Call Us
Why SCS
Why SCS
About Us
CEO`S Message
Our Management
Company Financials
Company Brochure
Auditor & Legal Advisor
Registered Agents
Careers
Online Trading
Open An Account
Online Account
Roshan Digital Account
PMEX Digital Account
Online Services
Transfer Funds
Commission Structure
Access Trading Platforms
TradeCast User Guide
Market Statistics
Market Valuations
Market Valuations
MSCI Stocks
Top Expected P/E Stocks
Top Dividend Yeild Stocks
Top Price to Book Value Stocks
Top EV/EBITDA Stocks
Top Performing Stocks (3 Months)
Top Performing Stocks (6 Months)
Lowest Paid Up Capital Stocks
Price Data
Index Overview
Daily Activity
Historical Indices
Historical Prices
Near 52 Weeks High - Low
Announcements
Announcements
Board Meetings
xPrice Dates
Portfolio Investments
Portfolio Investment Overview
Watch List
Watch List
PSX Heat Map
PSX Heat Map
Technical Analysis
Technical Tools
Realtime Advanced Chart
Realtime Advanced Multi Chart
Basic Charting Day-End
Index VS Stocks
Technical Report
New
Trading Signals
Trading Signals
Today`s Trading Signals
Trading Signal Performance
Fundamental Analysis
Financials
Index Snapshot
Sector`s Snapshot
Company`s Snapshot
Stock Screening
Stock Search
Stock Comparison
Research & Education
Research
Analyst Opinions
Market & Economic Reports
Technical Reports
General Reports
Company Reports
News Briefs
MTS Report
Valuation Matrix
MSCI PRO INDEXES
Guides
New to Investing
Guides
Website Guide
Workshop
Online Trading Terms
SLA From Software Vendor
Media
Video Gallery
Support
Investor Grievances
Contact Us
Branches
Teamviewer
Any Desk
Java
Snapshot /
MACTER - Macter International Ltd.
Snapshot Menu
Company Detail`s
Overview
Funds Holding
Analyst Opinion
Historical Prices
Profile
News
Announcements
Technicals
Overview
Basic Chart
Trading Signals
Analyst Coverage
Research Reports
Financials
Yearly Financials
Quarterly Financials
Distributions
Ratios
Yearly Ratios
Quarterly Ratios
MACTER - Macter International Ltd.
PHARMACEUTICALS
Share
Rs. 214.67
19.52 (10.00%)
Volume:Â
63,761
Market Cap:Â
9.83 bn
Avg Volume (12M):Â
4,262
Day`s Range
Rs. 199.88
Rs. 214.67
1 Month Range
Rs. 121.59
Rs. 214.67
6 Month Range
Rs. 86.96
Rs. 214.67
52 Week`s Range
Rs. 81.50
Rs. 214.67
Performance
1 Month
3 Month
6 Month
1 Year
70.49 %
91.67 %
142.59 %
131.15 %
Paid Up Capital:
458.11 mn
Authorized Capital:
650.00 mn
Total No. Shares:
45.81 mn
Free Float:
16.03 mn
Beta:
0.23
Facevalue:
10.00
Free Float %:
35.00 %
Year End:
June
Market Cap:
9.83 bn
Business Description
Macter International Limited was incorporated in Pakistan in 1992 as a private limited company and was converted into a public limited company in 2011. The principal activity of the company is to manufacture and market pharmaceutical products.
Earnings
Latest EPS
Upto 2025 1Q
EPS Last Quarter
2025 1Q
Last Annual EPS
Upto 2023 4Q
Price To Earning P/E
Upto 2023 4Q
Exp Price To Earning P/E
Upto 2025 1Q
Exp Earning Gowth
Upto 2025 1Q
Price Earning Growth
Upto 2025 1Q
Rs. 2.03
Rs. 2.03
Rs. 8.58
25.02 x
26.44 x
-5.36 %
-4.93 x
Important Ratios
Gross Margin
Upto 2023 4Q
Sales Growth (YoY)
2023 to 2024
Sales Growth (QoQ)
4Q 2024 to 1Q 2025
Enterprise Value Per Share
Upto 2024 3Q
Book Value Per Share
Upto 2024 3Q
Debt to Equity Ratio
Upto 2023 4Q
xPrice Date
Dividend: 10%
41.68 %
12.80%
2.16%
Rs. 226.64
Rs. 68.26
15.02 %
16-Oct-2024
Equity Ratios
Book Value
Upto 2024 3Q
Exp Book Value
Upto 2024 3Q
Book Value Growth
Upto 2023 4Q
Exp Book Value Growth
Upto 2024 3Q
Price To Book Value
Upto 2024 3Q
Exp Price To Book Value
Upto 2024 3Q
Return On Equity
Upto 2023 4Q
Exp Return On Equity
Upto 2024 3Q
Retention Ratio
Upto 2023 4Q
Exp Retention Ratio
Upto 2025 1Q
Equity To Assets Ratio
Upto 2023 4Q
Return On Assets
Upto 2023 4Q
Return On Cap Employed
Upto 2023 4Q
Rs. 68.26
Rs. 75.36
11.45 %
10.40 %
3.14 x
2.85 x
13.69 %
10.78 %
87.41 %
87.41 %
58.31 %
7.98 %
16.58 %
Dividends
Latest Dividend
Upto 2024 4Q
Dividend Last Quarter
2024 4Q
Last Annual Dividend
Upto 2023 4Q
Dividend Yield
Upto 2023 4Q
Expected Dividend
Upto 2025 1Q
Expected Dividend Yield
Upto 2025 1Q
Expected Dividend Growth
Upto 2025 1Q
Dividend Cover
Upto 2023 4Q
Payout Ratio
Upto 2023 4Q
Expected Payout Ratio
Upto 2025 1Q
Rs. 2.25
Rs. 1.00
Rs. 1.08
0.50 %
Rs. 2.25
1.05 %
108.33 %
7.94 x
12.59 %
12.59 %
Sales
Sales Per Share
Upto 2023 4Q
Exp Sales Per Share
Upto 2025 1Q
Price To Sales
Upto 2023 4Q
Exp Price To Sales
Upto 2025 1Q
Sales Per Share Growth
Upto 2023 4Q
Exp Sales P/S Growth
Upto 2025 1Q
Rs. 145.82
Rs. 189.00
1.47 x
1.14 x
25.78 %
29.61 %
Enterprise Value (EV)
EV To Sales
Upto 2023 4Q
Exp EV To Sales
Upto 2024 3Q
Enterprise Value
Upto 2024 3Q
Market Capitalization
Latest
EV To EBITDA
Upto 2023 4Q
EV Per Share
Upto 2024 3Q
1.57 x
1.44 x
Rs. 10.38 bn
Rs. 9.83 bn
13.15 x
Rs. 226.64
Cash
Cash Flow Per Share
Upto 2024 3Q
Cash Per Share
Upto 2024 3Q
Rs. 0.04
Rs. 0.04
Profitablility
Net Profit Margin
Upto 2023 4Q
Gross Profit Margin
Upto 2023 4Q
EBIT Margin
Upto 2023 4Q
EBITDA Margin
Upto 2023 4Q
Net Interest Margin
Upto 2023 4Q
5.88 %
41.68 %
8.85 %
11.93 %
928.24 %
Liquidity
Interest Cover
Upto 2023 4Q
Times Interest Earned
Upto 0
Inventory Turnover
Upto 2023 4Q
Asset Turnover
Upto 2023 4Q
Current Ratio
Upto 2024 3Q
Effective Tax Rate
Upto 2023 4Q
Quick Ratio
Upto 2023 4Q
Net Interest To Assets
Upto 2023 4Q
10.07 %
N/A %
3.76 %
135.69 %
1.87 x
29.45 %
0.54 x
56.56 %
Solvency
Long Debt To Equity
Total Debt To Equity
Long Debt To Assets
Upto 2024 3Q
Total Debt To Assets
Upto 2024 3Q
17.60 %
15.02 %
10.58 %
9.03 %